THE Therapeutic Goods Administration has added four new items to its Prescribing Medicines in Pregnancy database.
The additions include gabapentin (pregnancy category B3), daratumumab (category C), guanfacine hydrocholoride (category B3) and pralatrexate (category D) - see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Oct 17